A panelist discusses how real-world evidence from a large cohort study (n = 31521) presented at AAD 2025 reveals notable ...

Several characteristics, including BMI and Charlson Comorbidity Index, were associated with super response to biologics in patients with psoriasis.

Women with psoriasis show shorter drug survival for biologics, including IL-17/23 inhibitors, due to lower satisfaction and ...

A RECENT study has highlighted key biological and clinical factors linked to resistance to biologic therapies in patients ...

Discover a study that assessed the risk of hospitalisation for serious infections based on different categories of systemic ...

Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Biologics targeting interleukin-12, -23, and -17 were ...

A decade-long study finds that obesity is associated with a significantly increased risk for biologic treatment failure in ...

Patients with moderate to severe psoriasis treated with ustekinumab ... Research Database during 2011-2021 who were treated with biologics (6769 patients) or traditional systemic treatments ...